Roche Backs Off Mircera Suit In India
This article was originally published in PharmAsia News
Executive Summary
Roche has dropped its suit against Intas Pharmaceuticals over the alleged infringement of its patents pertaining to Mircera, after the Indian firm apparently established that its product is "different". But both sides appear keen to keep the matter alive, suggesting that they would seek appropriate remedies in the event of fresh "cause of action".